FDA Approves Energex Systems, Inc. Non-Drug Therapy For HIV Research (Medical News Today)
Energex Systems, Inc. announced that it has been granted approval from the Federal Food and Drug Administration (FDA) to utilize its experimental HemoModulation therapy in a clinical trial of HIV infected patients. The purpose of the study will be to demonstrate safety and monitor viral load changes in patients who are not yet eligible for antiviral drug therapy.

US Cong to probe FDA's Ranbaxy case (IBN live)
It wants to know if FDA allowed Ranbaxy's faulty medicine deliberately.

FDA Advisory Committee Provides Opinion Of DORIBAX(TM) For The Treatment Of Hospital Acquired Pneumonia (Medical News Today)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted in favor of the efficacy and safety data for DORIBAX(TM) (doripenem for injection) for the treatment of hospital-acquired pneumonia, or nosocomial pneumonia (NP), and ventilator-associated pneumonia (VAP).